BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17889818)

  • 1. Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation.
    Thornton I; Puri A; Xu M; Krueger RR
    Am J Ophthalmol; 2007 Nov; 144(5):673-681. PubMed ID: 17889818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of laser epithelial keratomileusis with and without mitomycin C performed to correct myopia in thin corneas: a 15-month follow-up.
    de Benito-Llopis L; Teus MA; Sánchez-Pina JM; Fuentes I
    Am J Ophthalmol; 2008 May; 145(5):807-12. PubMed ID: 18342832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topography-guided customized laser-assisted subepithelial keratectomy for the treatment of postkeratoplasty astigmatism.
    Rajan MS; O'Brart DP; Patel P; Falcon MG; Marshall J
    J Cataract Refract Surg; 2006 Jun; 32(6):949-57. PubMed ID: 16814052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wavefront-guided photorefractive keratectomy in eyes with prior radial keratotomy: a multicenter study.
    Koch DD; Maloney R; Hardten DR; Dell S; Sweeney AD; Wang L
    Ophthalmology; 2009 Sep; 116(9):1688-1696.e2. PubMed ID: 19643486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between femtosecond laser-assisted sub-Bowman keratomileusis vs laser subepithelial keratectomy to correct myopia.
    de Benito-Llopis L; Teus MA; Gil-Cazorla R; Drake P
    Am J Ophthalmol; 2009 Dec; 148(6):830-6.e1. PubMed ID: 19781686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of wavefront-optimized surface ablation.
    Randleman JB; Loft ES; Banning CS; Lynn MJ; Stulting RD
    Ophthalmology; 2007 May; 114(5):983-8. PubMed ID: 17337064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between three- and six-month postoperative refractive and visual results after laser epithelial keratomileusis with mitomycin C.
    de Benito-Llopis L; Teus MA; Hernández-Verdejo JL
    Am J Ophthalmol; 2009 Jan; 147(1):71-76.e2. PubMed ID: 18774546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced application time for prophylactic mitomycin C in photorefractive keratectomy.
    Virasch VV; Majmudar PA; Epstein RJ; Vaidya NS; Dennis RF
    Ophthalmology; 2010 May; 117(5):885-9. PubMed ID: 20163867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of surface ablation retreatments using mitomycin C.
    de Benito-Llopis L; Teus MA
    Am J Ophthalmol; 2010 Sep; 150(3):376-380.e2. PubMed ID: 20570239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of laser-assisted subepithelial keratectomy to treat residual refractive errors after laser in situ keratomileusis.
    Cagil N; Aydin B; Ozturk S; Hasiripi H
    J Cataract Refract Surg; 2007 Apr; 33(4):642-7. PubMed ID: 17397737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes.
    Gambato C; Ghirlando A; Moretto E; Busato F; Midena E
    Ophthalmology; 2005 Feb; 112(2):208-18; discussion 219. PubMed ID: 15691552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia.
    Thornton I; Xu M; Krueger RR
    J Refract Surg; 2008 Jan; 24(1):S68-76. PubMed ID: 18269154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of epi-LASIK: 1-year results of on- and off-flap procedures with and without mitomycin-C.
    Kim ST; Koh JW; Yoon GJ; Yang SW
    Br J Ophthalmol; 2010 May; 94(5):592-6. PubMed ID: 19955194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The U.S. Army Surface Ablation Study: comparison of PRK, MMC-PRK, and LASEK in moderate to high myopia.
    Sia RK; Ryan DS; Edwards JD; Stutzman RD; Bower KS
    J Refract Surg; 2014 Apr; 30(4):256-64. PubMed ID: 24702577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of laser-assisted subepithelial keratectomy without mitomycin-C for the treatment of high myopia.
    Aydin B; Cagil N; Erdoğan S; Erdurmus M; Hasiripi H
    J Cataract Refract Surg; 2008 Aug; 34(8):1280-7. PubMed ID: 18655977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of mitomycin C on corneal regrowth after laser-assisted sub-epithelial keratectomy (LASEK)].
    De Benito-Llopis L; Teus MA; Drake-Casanova P
    Arch Soc Esp Oftalmol; 2011 Jul; 86(7):213-7. PubMed ID: 21798407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of visual results between laser-assisted subepithelial keratectomy and epipolis laser in situ keratomileusis to correct myopia and myopic astigmatism.
    Teus MA; de Benito-Llopis L; García-González M
    Am J Ophthalmol; 2008 Sep; 146(3):357-362. PubMed ID: 18614136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser in situ keratomileusis versus surface ablation: visual outcomes and complications.
    Ghadhfan F; Al-Rajhi A; Wagoner MD
    J Cataract Refract Surg; 2007 Dec; 33(12):2041-8. PubMed ID: 18053901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of higher-order aberrations after conventional laser in situ keratomileusis and laser epithelial keratomileusis for myopia using the technolas 217z laser platform.
    Kirwan C; O'Keefe M
    Am J Ophthalmol; 2009 Jan; 147(1):77-83. PubMed ID: 18775529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized dose-response analysis of mitomycin-C to prevent haze after photorefractive keratectomy for high myopia.
    Hofmeister EM; Bishop FM; Kaupp SE; Schallhorn SC
    J Cataract Refract Surg; 2013 Sep; 39(9):1358-65. PubMed ID: 23830559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.